Xarelto Lawsuits Continue with Wrongful Death Case
Xarelto has been named in another lawsuit due to the death of an elderly man in Missouri who was prescribed the medication in December 2012.
Xarelto has been a controversial blood thinning drug for quite some time. Many lawsuits have alleged the manufacturers of the drug have concealed information about the dangers and bleeding associated with the drug. Due to the large number of lawsuits, multi-district litigation was formed to consolidate the cases against Xarleto manufacturers, Johnson & Johnson and Janssen Pharmaceuticals.
The most recent case involved is the wrongful death of a Missouri man who died in May 2013, after taking the drug since December 2012. His widowed wife is seeking compensation for her spouse’s treatment and for her pain, suffering and anguish. After being prescribed the drug, the man was taken to the emergency room in May 2013 where he was diagnosed with cerebral hemorrhage. Although in intensive care, they were unable to stop the brain bleeding and he passed away soon after.
Although the drug was approved by the Food and Drug Administration in 2011 as treatment for clotting after knee or hip surgeries, the manufactures failed to note that the drug could cause an increased risk in bleeding. The drug was received as an alternative to warfarin, an anti-coagulant drug. Xarelto was marketed as a drug which people could maintain an active lifestyle with and that patients would not need frequent trips to the clinic. Unfortunately, this is a drug that should only be used under close supervision. It also has strong side effects of pulmonary embolism, which is what the drug is intended to prevent.
Although the Xarelto class action is still in the very early stages, new claims are being added every month and the drug still continues to be prescribed. In fact, drug sales rose 41 percent in quarter one of 2015.
If you or someone you know has been injured as a result of Xarelto or another drug, contact our law offices today for a free consultation.